FZD10
Basic information
Region (hg38): 12:130162459-130165740
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FZD10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 0 | 0 |
Variants in FZD10
This is a list of pathogenic ClinVar variants found in the FZD10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-130162987-G-T | not specified | Uncertain significance (Oct 29, 2021) | ||
12-130162992-C-T | not specified | Uncertain significance (Dec 28, 2022) | ||
12-130163003-A-G | not specified | Uncertain significance (Oct 16, 2024) | ||
12-130163020-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
12-130163069-A-G | not specified | Uncertain significance (Jun 18, 2024) | ||
12-130163129-G-A | not specified | Uncertain significance (Dec 21, 2022) | ||
12-130163193-G-A | not specified | Uncertain significance (Oct 09, 2024) | ||
12-130163214-A-T | not specified | Uncertain significance (May 17, 2023) | ||
12-130163289-A-G | not specified | Uncertain significance (Dec 02, 2022) | ||
12-130163305-G-C | not specified | Uncertain significance (Dec 22, 2023) | ||
12-130163311-G-C | not specified | Uncertain significance (Mar 26, 2024) | ||
12-130163332-C-G | not specified | Uncertain significance (Nov 14, 2024) | ||
12-130163359-C-A | not specified | Uncertain significance (Jan 17, 2024) | ||
12-130163401-C-A | not specified | Uncertain significance (Aug 28, 2024) | ||
12-130163402-G-A | not specified | Uncertain significance (Dec 09, 2024) | ||
12-130163442-C-T | not specified | Uncertain significance (Nov 09, 2024) | ||
12-130163476-G-C | not specified | Uncertain significance (Nov 21, 2022) | ||
12-130163480-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
12-130163484-C-G | not specified | Uncertain significance (Aug 20, 2024) | ||
12-130163486-C-A | not specified | Uncertain significance (Dec 19, 2023) | ||
12-130163504-G-T | not specified | Uncertain significance (Apr 01, 2024) | ||
12-130163543-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
12-130163565-C-T | not specified | Uncertain significance (Oct 12, 2022) | ||
12-130163606-G-A | not specified | Uncertain significance (Jun 21, 2023) | ||
12-130163682-T-A | not specified | Uncertain significance (Apr 15, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FZD10 | protein_coding | protein_coding | ENST00000229030 | 1 | 3282 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000528 | 0.974 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0587 | 358 | 361 | 0.991 | 0.0000192 | 3812 |
Missense in Polyphen | 178 | 193.77 | 0.91863 | 2113 | ||
Synonymous | -0.217 | 164 | 161 | 1.02 | 0.00000924 | 1178 |
Loss of Function | 1.98 | 8 | 16.7 | 0.478 | 7.28e-7 | 170 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for Wnt proteins. Functions in the canonical Wnt/beta-catenin signaling pathway (By similarity). The canonical Wnt/beta-catenin signaling pathway leads to the activation of disheveled proteins, inhibition of GSK-3 kinase, nuclear accumulation of beta-catenin and activation of Wnt target genes. A second signaling pathway involving PKC and calcium fluxes has been seen for some family members, but it is not yet clear if it represents a distinct pathway or if it can be integrated in the canonical pathway, as PKC seems to be required for Wnt-mediated inactivation of GSK-3 kinase. Both pathways seem to involve interactions with G-proteins. May be involved in transduction and intercellular transmission of polarity information during tissue morphogenesis and/or in differentiated tissues (Probable). {ECO:0000250|UniProtKB:Q8BKG4, ECO:0000305}.;
- Pathway
- Gastric cancer - Homo sapiens (human);mTOR signaling pathway - Homo sapiens (human);Cushing,s syndrome - Homo sapiens (human);Breast cancer - Homo sapiens (human);HTLV-I infection - Homo sapiens (human);Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human);Basal cell carcinoma - Homo sapiens (human);Hepatocellular carcinoma - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);Proteoglycans in cancer - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Wnt signaling pathway - Homo sapiens (human);Melanogenesis - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Association Between Physico-Chemical Features and Toxicity Associated Pathways;Wnt Signaling Pathway and Pluripotency;EMT transition in Colorectal Cancer;Wnt Signaling Pathway;Signaling by GPCR;Signal Transduction;GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;Class B/2 (Secretin family receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i;Wnt Canonical;Wnt signaling network;Wnt Mammals
(Consensus)
Recessive Scores
- pRec
- 0.155
Intolerance Scores
- loftool
- 0.317
- rvis_EVS
- -0.91
- rvis_percentile_EVS
- 9.9
Haploinsufficiency Scores
- pHI
- 0.387
- hipred
- hipred_score
- ghis
- 0.601
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.333
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fzd10
- Phenotype
- normal phenotype;
Zebrafish Information Network
- Gene name
- fzd10
- Affected structure
- Kupffer's vesicle
- Phenotype tag
- abnormal
- Phenotype quality
- decreased amount
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;neuron differentiation;regulation of actin cytoskeleton organization;negative regulation of GTPase activity;non-canonical Wnt signaling pathway;non-canonical Wnt signaling pathway via JNK cascade;positive regulation of JUN kinase activity;positive regulation of GTPase activity;canonical Wnt signaling pathway;cellular response to retinoic acid
- Cellular component
- nucleoplasm;cytoplasm;plasma membrane;integral component of plasma membrane;cell surface
- Molecular function
- G protein-coupled receptor activity;protein binding;Wnt-protein binding;Wnt-activated receptor activity